Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Blocking COMPASS Promoter Activation Makes HDAC-Inhibited Gastric Cancer Keep Genes Turned Off During Recovery

Updated

Abstract

WDR5 abundance and baseline H3K4me3 levels are associated with sensitivity to combined HDAC and WDR5 WIN-pocket inhibition.

  • Histone deacetylase inhibitors increase chromatin acetylation but show variable effectiveness in solid tumors.
  • The study identifies the WDR5 WIN pocket as crucial for maintaining chromatin-associated COMPASS and promoter-proximal H3K4me3 levels.
  • Disruption of the WDR5 WIN pocket leads to reduced recovery of COMPASS components and lower H3K4me3 at specific promoters.
  • This disruption results in higher H3K27 acetylation, decreased H3K4me3, and diminished transcriptional output.
  • Data indicate that HDAC inhibitor response may be influenced by promoter licensing through the WDR5-COMPASS H3K4 methylation axis.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free